Additionally, the loss of the tumor suppressor gene phosphatase and tensin homolog (PTEN) is associated with a worse prognosis in patients with HER2-amplified breast cancer; however, this is not related to trastuzumab resistance. The gene discussed is ERBB2; the disease is breast cancer.